Ovarian Cancer Trial, Recruiting (NCT05364879)

Ovarian Cancer Trial, Recruiting NCT05364879 Sponsor: Nova Scotia Health Authority Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05364879 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You have been officially diagnosed with stage III or IV ovarian cancer
You are planning to have surgery to remove tumors as part of your cancer treatment
Your surgery is scheduled at least 4 weeks after you would enroll in the study
You are able to attend exercise sessions either in person or online
You are fluent in English
Your cancer doctor has given approval for you to participate

Who may not be able to join:

You have already had your tumor removal surgery
You have an unstable heart or breathing condition, an injury, or another health condition that could make exercising unsafe for you
You have significant memory or thinking difficulties that would prevent you from giving consent or following exercise instructions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Scott Grandy, PhD, Nova Scotia Health

Phone: 902-494-1145

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05364879

Sponsor: Nova Scotia Health Authority

Phase: Not Applicable

Status: Recruiting

Condition: Ovarian Cancer

Trial contact: 902-494-1145

More information: https://clinicaltrials.gov/study/NCT05364879

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You have been officially diagnosed with stage III or IV ovarian cancer
You are planning to have surgery to remove tumors as part of your cancer treatment
Your surgery is scheduled at least 4 weeks after you would enroll in the study
You are able to attend exercise sessions either in person or online
You are fluent in English
Your cancer doctor has given approval for you to participate

Who may not be able to join:

You have already had your tumor removal surgery
You have an unstable heart or breathing condition, an injury, or another health condition that could make exercising unsafe for you
You have significant memory or thinking difficulties that would prevent you from giving consent or following exercise instructions

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Nova Scotia Health Authority

Registry

ClinicalTrials.gov

Start date

3 January 2023

Est. completion

31 August 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Frailty Change (baseline to post exercise intervention); Frailty Change (baseline to 1-month post surgery); Frailty Change (baseline to 3-months post surgery); Surgical Complexity Score (1-month post surgery); Post-Surgical Outcomes (1-month post surgery); Surgical Complications (1-month post surgery); Chemotherapy completion rates (End of Cycle 1); Chemotherapy completion rates (End of Cycle 2); Chemotherapy completion rates (End of Cycle 3); Chemotherapy completion rates (End of Cycle 4); Chemotherapy completion rates (End of Cycle 5); Chemotherapy completion rates (End of Cycle 6)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov